LoginSignup
image de profil
Get_Rich_or_Die_Tryin@Get_Rich_or_Die_Tryin
1Sem.
Where do you see the gap closing? I see the gap right just above the current price level. Good luck with that—but it might be tough to close it without a significant catalyst.🤷🏼‍♂️
•
3
•
image de profil
jkb92@jkb92
1Sem.
@Get_Rich_or_Die_Tryin The upward gap from late March has already closed today at 196 SEK. In my opinion, it doesn't necessarily need any catalysts. The technical setup is good. After all, not all of the recent price movements have been driven by news. In my opinion, it’s safe to buy now (this is not investment advice😁).
•
1
•
image de profil
Get_Rich_or_Die_Tryin@Get_Rich_or_Die_Tryin
1Sem.
I was focusing on the downward gap on the weekly chart. But that's been filled now, too. So there might be some movement. Still, it's not a stock I'm interested in, but I wish you the best of luck.👍🏻
•
2
•
image de profil
jkb92@jkb92
1Sem.
@Get_Rich_or_Die_Tryin I don't see any downward gap there at all. On what date?
••
image de profil
Get_Rich_or_Die_Tryin@Get_Rich_or_Die_Tryin
1Sem.
@jkb92 My fault, no gap.👍🏻 Misled by low trading volume and the market close in Stockholm🫣😅.
•
1
•
image de profil
jkb92@jkb92
1Sem.
@Get_Rich_or_Die_Tryin I see. I can think of one “catalyst”: potential widespread restructuring, including in the pharmaceutical industry, among other sectors.
•
1
•
image de profil
Get_Rich_or_Die_Tryin@Get_Rich_or_Die_Tryin
1Sem.
@jkb92 But they're more like MedTech, right? 🤔 At least that's my impression. 😅 It's hard to tell the difference here.
•
1
•
image de profil
jkb92@jkb92
1Sem.
@Get_Rich_or_Die_Tryin Yeah, in a broader sense. They haven't been doing well lately, either.
•
1
•